Institutional Ownership
Theriva Biologics Inc
CUSIP 87164U508COM NEWTOVXQ1 2026
Institutional Holders
20
13F filers
Shares Held
1.53M
Aggregate institutional
Institutional Value
$250.3K
Q1 2026
Net New Holders
+0
3 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions3
Increased5
Decreased5
Sold out3
Institutional Holders
20 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 450.3K | $88.2K | +238.2K | Added |
| 2 | Ubs Group AG | 225.6K | $44.2K | +34.2K | Added |
| 3 | Jane Street Group, LLC | 177.0K | $34.7K | +177.0K | New |
| 4 | Ikarian Capital, LLC | 112.1K | $21.9K | 0 | Held |
| 5 | Two Sigma Securities, LLC | 105.2K | $20.6K | +62.3K | Added |
| 6 | Xtx Topco Ltd | 94.6K | $18.5K | +55.2K | Added |
| 7 | Boothbay Fund Management, LLC | 27.6K | $5.4K | 0 | Held |
| 8 | Morgan Stanley | 23.6K | $4.6K | −176.4K | Reduced |
| 9 | Stonex Group Inc. | 22.3K | $4.4K | −14.9K | Reduced |
| 10 | Two Sigma Investments, LP | 15.4K | $3.0K | −26.9K | Reduced |
10 more institutional holders on Premium
See every fund holding Theriva Biologics Inc, with full quarter-over-quarter share changes.
Unlock all holders